A trial of a dissolvable heart stent for long blockages
Part of Heart & circulation, Pain clinical trials.
This trial tests a new type of stent made from magnesium that slowly dissolves over time. It is for people who have a long blockage in a heart artery that has not been treated before and may be a good option for those who are stable and have not had a recent heart attack.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have stable chest pain or had a mild heart attack that is now under control
- You have one or two new blockages in separate heart arteries, each longer than 28 mm but no more than 38 mm
- You are able to take two blood-thinning medicines (like aspirin plus clopidogrel or similar)
- You have not had a stroke or mini-stroke in the last 6 months
- Your kidney function is good (creatinine level is not too high)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
This study compares two types of devices used to open blocked heart arteries during a heart attack or unstable chest pain: one is a scaffold made of magnesium that dissolves over time, the other is a permanent stent with a coating that releases medicine. The goal is to see which device works better for patients like you.
This trial tests a new dissolvable magnesium scaffold to treat blockages in heart arteries. It is designed for people with stable heart pain or certain recent heart attacks, and it aims to open blocked arteries and then slowly dissolve over time.
This trial tests a new stent (a small mesh tube) to open narrowed heart arteries and improve blood flow. It may help people with multiple blocked arteries who are having a procedure to widen them.
This trial tests a longer-than-usual drug-coated stent (Orsiro Mission) for treating long blockages in heart arteries. It aims to see if the stent is safe and effective for people with coronary artery disease.
This trial tests a new stent (a small mesh tube placed in your heart artery to keep it open) called MiStent II. The stent slowly releases a medicine to help prevent the artery from narrowing again. If you have coronary artery disease and need a stent, this study may help improve your treatment.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.